GO
Loading...

Regeneron CEO: More opportunities to grow Eylea

Tuesday, 5 Nov 2013 | 6:25 PM ET

Regeneron Pharmaceuticals president & CEO Dr. Leonard Schleifer provides insight into the early stages of its macular degeneration drug Eylea, its strong partnership with Sanofi and other drugs in its pipeline to treat allergic diseases.